Skip to main content

Security report for shire.com

Takeda Pharmaceutical Company Limited · Healthcare · Japan

Medium risk. 4 critical or high findings in Security headers and SSL/TLS.

Security score

74/100

Risk levelMedium

0–100, higher is better. How it is calculated

Takeda Pharmaceutical Company Limited is a globally recognized, patient-focused biopharmaceutical company headquartered in Tokyo, Japan. The company emphasizes research and development to bring innovative healthcare solutions worldwide. Their website reflects a mature digital presence with comprehensive corporate governance, ethics, and sustainability disclosures, targeting healthcare professionals, patients, investors, and partners. The business model centers on pharmaceutical R&D, manufacturing, and clinical trials, positioning Takeda as a leading entity in the healthcare sector. Technically, the website leverages modern web technologies including React and Next.js, ensuring good mobile optimization, accessibility, and SEO practices. The site loads with moderate performance and employs standard security headers and HTTPS, indicating a strong technical foundation. Analytics usage includes Matomo and Google Tag Manager, with appropriate cookie consent mechanisms in place, reflecting good privacy compliance. Security posture is robust with enforced HTTPS, security headers, and no visible vulnerabilities or exposed sensitive data. However, the absence of a dedicated security policy or incident response contact page suggests areas for improvement. The WHOIS data is missing or unavailable, which is unusual for a major corporation, but the website's content and branding strongly support legitimacy. Overall, Takeda's website demonstrates a high level of professionalism, security, and compliance, suitable for its enterprise scale and industry. Strategic recommendations include publishing explicit security policies, incident response contacts, and vulnerability disclosure information to enhance transparency and trust.

Scanned

NIS2 and GDPR posture

GDPR outside view
88/ 100 · Low
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

4 findings rated critical or high. Fix these first.

  1. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing X-Frame-Options header

      Prevents clickjacking attacks

      What to do: Add "X-Frame-Options: DENY" or "X-Frame-Options: SAMEORIGIN"

    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…

  2. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • High

      Weak Protocols Supported

      Server supports weak protocols: TLSv1.1

      What to do: Disable TLS 1.0, TLS 1.1, and all SSL versions

      • CWE-327
      • OWASP A04:2025
      • ASVS V12.1.1
    • High

      Weak SSL Key Length

      SSL certificate uses 256-bit key, which is considered weak

      What to do: Use at least 2048-bit RSA or 256-bit ECC key

      • CWE-326
      • OWASP A04:2025
      • Mozilla TLS: Mozilla Server Side TLS 6.0 intermediate: rsa_key_size 2048

Need hands-on remediation? Email guard@offseq.com

Keep watching shire.com

This scan found 19 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. See sample alerts.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
57
Security headers
35
Email security
85
DNS health
80
Network security
100
GDPR outside view
88
Average
74

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

Takeda operates as a global biopharmaceutical company with a strong emphasis on R&D-driven healthcare solutions. The company maintains a significant market position with a broad portfolio of products and clinical trials. Their business model is focused on innovation, manufacturing, and global distribution of pharmaceutical products. The website indicates a well-established partnership ecosystem through social media and investor relations. Growth indicators include comprehensive sustainability and corporate responsibility initiatives. The company targets multiple customer segments including healthcare providers, patients, and investors, reflecting a diversified approach to market engagement.

Security posture

The website exhibits a mature security posture with HTTPS enforced and multiple security headers implemented, including HSTS, X-Content-Type-Options, and Content-Security-Policy. No exposed sensitive data or vulnerable libraries were detected in the HTML content. Forms appear secure with proper labeling and no signs of insecure data handling. However, the absence of a published security policy or incident response contact reduces transparency. No vulnerability disclosure or security.txt file was found, which could be improved to facilitate responsible vulnerability reporting. Overall, the security maturity is high but could benefit from enhanced communication of security practices.

Recommendations

  1. Publish a dedicated security policy page outlining security practices and commitments.
  2. Provide clear incident response contact information, such as a security@ or abuse@ email address.
  3. Implement and publish a vulnerability disclosure policy or security.txt file to encourage responsible reporting.
  4. Enhance transparency by listing relevant certifications and compliance frameworks (e.g., ISO 27001, NIST).
  5. Regularly review and update privacy and cookie policies to maintain GDPR and global compliance.

Contact details published on the site

Addresses
Legal name
Takeda Pharmaceutical Company Limited
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Takeda Pharmaceutical Company Limited
Description
Takeda is a patient-focused, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future.
Key services
Pharmaceutical research and development, Manufacturing and supply of medicines, Clinical trials
Content quality
excellent
Branding
consistent

Technology

Stack
React, Next.js, JavaScript, CSS
Frameworks
Next.js
Performance
moderate
Mobile
excellent
Accessibility
good
SEO
good

Security

Observed score
90/100
Good practices seen
  • HTTPS enforced
  • Use of security headers
  • No exposed sensitive data in HTML
  • Secure forms with proper labeling

Analytics and tracking

Services
Matomo
Tracking level
moderate
Privacy practices
good

Advertising

Tracking pixels
Matomo
Transparency
good

Site quality

Design
excellent
User experience
excellent
Content relevance
excellent
Navigation
excellent
Professionalism
excellent
Trustworthiness
high

Key observations

  1. Website is fully accessible with rich content and navigation.
  2. Strong corporate governance and responsibility disclosures.
  3. Comprehensive privacy and cookie policies with consent mechanisms.
  4. Use of modern web technologies and frameworks.
  5. No signs of malicious or suspicious content.
  6. WHOIS data is missing or unavailable, which is unusual for a major corporation domain.
Technical notes

Notes

The website is built using modern JavaScript frameworks, primarily React and Next.js, which support server-side rendering and improved SEO. The site is mobile-optimized with responsive design and accessibility features, ensuring a good user experience across devices. Performance is moderate, with multiple CSS and JavaScript chunks loaded asynchronously. The presence of cookie consent scripts and analytics tools like Matomo and Google Tag Manager indicates a mature approach to user tracking and privacy. No CMS was explicitly detected, suggesting a custom or proprietary solution. Hosting provider details were not discernible from the content. Overall, the technical infrastructure supports a robust, scalable, and user-friendly digital presence.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Earlier scans of this domain

  1. 46/100High26 findingsView report
Reviews of this site

Share your experience with shire.com. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review shire.com.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.